JPS5523254B2 - - Google Patents
Info
- Publication number
- JPS5523254B2 JPS5523254B2 JP1161774A JP1161774A JPS5523254B2 JP S5523254 B2 JPS5523254 B2 JP S5523254B2 JP 1161774 A JP1161774 A JP 1161774A JP 1161774 A JP1161774 A JP 1161774A JP S5523254 B2 JPS5523254 B2 JP S5523254B2
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1161774A JPS5523254B2 (de) | 1974-01-28 | 1974-01-28 | |
CA206,978A CA1023662A (en) | 1974-01-28 | 1974-08-14 | Hb ag vaccine high in antibody productivity |
GB3604674A GB1462298A (en) | 1974-01-28 | 1974-08-15 | Antibody productive hb ag vaccine and process for its preparation |
FR7429291A FR2258864B1 (de) | 1974-01-28 | 1974-08-27 | |
DE2440926A DE2440926C3 (de) | 1974-01-28 | 1974-08-27 | Injizierbarer inaktivierter Impfstoff gegen Hepatitis B und Verfahren zu seiner Herstellung |
CH1636974A CH617350A5 (en) | 1974-01-28 | 1974-12-10 | Process for the preparation of HB-Ag vaccines with high-level antibody formation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1161774A JPS5523254B2 (de) | 1974-01-28 | 1974-01-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS50105817A JPS50105817A (de) | 1975-08-20 |
JPS5523254B2 true JPS5523254B2 (de) | 1980-06-21 |
Family
ID=11782869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1161774A Expired JPS5523254B2 (de) | 1974-01-28 | 1974-01-28 |
Country Status (6)
Country | Link |
---|---|
JP (1) | JPS5523254B2 (de) |
CA (1) | CA1023662A (de) |
CH (1) | CH617350A5 (de) |
DE (1) | DE2440926C3 (de) |
FR (1) | FR2258864B1 (de) |
GB (1) | GB1462298A (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4017360A (en) * | 1975-05-14 | 1977-04-12 | Merck & Co., Inc. | Method for purifying hepatitis B antigen |
GB1571829A (en) | 1976-04-06 | 1980-07-23 | Lafon Labor | Sulphur-containing diaryl compounds and oxygen-containing diaryl compounds |
JPS591981B2 (ja) * | 1976-08-27 | 1984-01-14 | 株式会社ミドリ十字 | HBs抗体検出用受身赤血球凝集試験用担体の製造方法 |
US4639371A (en) * | 1984-10-02 | 1987-01-27 | New York Blood Center, Inc. | Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom |
-
1974
- 1974-01-28 JP JP1161774A patent/JPS5523254B2/ja not_active Expired
- 1974-08-14 CA CA206,978A patent/CA1023662A/en not_active Expired
- 1974-08-15 GB GB3604674A patent/GB1462298A/en not_active Expired
- 1974-08-27 DE DE2440926A patent/DE2440926C3/de not_active Expired
- 1974-08-27 FR FR7429291A patent/FR2258864B1/fr not_active Expired
- 1974-12-10 CH CH1636974A patent/CH617350A5/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FR2258864A1 (de) | 1975-08-22 |
DE2440926A1 (de) | 1975-07-31 |
DE2440926C3 (de) | 1978-11-30 |
FR2258864B1 (de) | 1978-06-30 |
CA1023662A (en) | 1978-01-03 |
CH617350A5 (en) | 1980-05-30 |
DE2440926B2 (de) | 1978-04-06 |
JPS50105817A (de) | 1975-08-20 |
GB1462298A (en) | 1977-01-19 |